Mortality Outcomes and Predictors of Failed Thrombolysis following STEMI Thrombolysis in a Non-PCI Capable Tertiary Hospital
DOI:
https://doi.org/10.53350/pjmhs02025193.5Keywords:
STEMI, thrombolysis, non-PCI hospital, failed thrombolysis, mortality, predictors.Abstract
Background: Thrombolysis is an essential treatment for ST elevation myocardial infarction (STEMI) in situations where primary percutaneous coronary intervention (PCI) is unavailable. This research examines mortality outcomes and determines predictors of unsuccessful thrombolysis in a tertiary hospital lacking PCI capabilities.
Methods: A retrospective analysis was conducted on 550 patients who received thrombolysis following STEMI at a non-PCI capable tertiary hospital from 2018 to 2023. Patient data, including demographics, clinical presentation, treatment protocols, and outcomes, were reviewed. Failed thrombolysis was defined as the absence of >50% resolution of ST-segment elevation within 90 minutes post-thrombolysis. Multivariate logistic regression analysis was used to identify predictors of failed thrombolysis.
Results: The mean age of the patients was 60 ± 10 years, with 70% being male. Thrombolysis was successful in 75% of cases, while 25% (138 patients) experienced failed thrombolysis. The in-hospital mortality rate was 12% for the overall cohort, but significantly higher at 30% among those with failed thrombolysis. Predictors of failed thrombolysis included advanced age (>65 years), delayed presentation (>6 hours from symptom onset), anterior infarction, and higher Killip class at presentation (III-IV). Multivariate analysis identified delayed presentation (OR 2.5, 95% CI 1.7-3.7) and anterior infarction (OR 3.1, 95% CI 2.1-4.5) as the strongest predictors of failed thrombolysis.
Conclusion: Failed thrombolysis following STEMI is associated with significantly higher mortality in a non-PCI capable tertiary hospital setting. Delayed presentation and anterior infarction are key predictors of thrombolysis failure, highlighting the need for early intervention and potential transfer to PCI-capable centers.
References
Koh HP, Md Redzuan A, Mohd Saffian S, Hassan H, R. Nagarajah J, Ross NT. Mortality outcomes and predictors of failed thrombolysis following STEMI thrombolysis in a non-PCI capable tertiary hospital: a 5-year analysis. Internal and Emergency Medicine. 2023 Jun;18(4):1169-80.
Koh HP, Redzuan AM, Saffian SM, Nagarajah JR, Ross NT, Hassan H. Impact of covid-19 pandemic on stemi thrombolysis and emergency department's performance in a non-pci capable tertiary hospital. The American Journal of Emergency Medicine. 2022 Oct 1;60:9-14.
Walters D, Mahmud E. Thrombolytic therapy for st-elevation myocardial infarction presenting to non-percutaneous coronary intervention centers during the COVID-19 crisis. Current Cardiology Reports. 2021 Oct;23:1-8.
Ahmad F, Ullah I, Farhad A, Ahmad W, Rauf MA. Thrombolytic therapy success rate and time to thrombolysis in patients with st-elevation myocardial infarction.
Rahman MA. Complications And In-Hospital Mortality Rates After PCI of Percutaneous Coronary Intervention In St Elevation Myocardial Infraction. International Journal of Dental and Clinical Study. 2020;1(1):01-10.
Koh HP, Nagarajah JR, Hassan H, Ross NT. Bleeding characteristics and mortality outcomes following ST-elevation myocardial infarction thrombolysis: a 5-year analysis in an Asian population. World Journal of Emergency Medicine. 2024:0.
Wu C, Li L, Wang S, Zeng J, Yang J, Xu H, Zhao Y, Wang Y, Li W, Jin C, Gao X. Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry. BMC Cardiovascular Disorders. 2023 Feb 22;23(1):103.
Wang Q, Zan C, Li F, Li Y, Wang F, Wang T, Zhao X, Du Y. The impact of admission modes on the treatment outcome and in-hospital mortality rate of STEMI patients undergoing PPCI. Scientific Reports. 2024 Aug 15;14(1):18932.
Chao WU, Zhang QY, Ling LI, Zhang XX, Cai YC, Yang JG, Xu HY, Zhao YY, Yang WA, Wei LI, Chen JI. Long-Term Prognosis of Different Reperfusion Strategies for ST-Segment Elevation Myocardial Infarction in Chinese County-Level Hospitals: Insight from China Acute Myocardial Infarction Registry. Biomedical and Environmental Sciences. 2023 Sep 1;36(9):826-36.
Yakubu AS, Ahadzi D. Quality of acute coronary syndrome care and in-hospital outcome in a resource-poor setting in Northern Ghana.
Iqbal AM, Jamal SF, Ahmed A, Khan H, Khan W, Ahmed F, Santosh R, Ghazni MS, Mubarik A, Hanif B. Impact of Delayed Pain to Needle and Variable Door to Needle Time On In-Hospital Complications in Patients With ST-Elevation Myocardial Infarction Who Underwent Thrombolysis: A Single-Center Experience. Cureus. 2022 Jan;14(1).
Mentuch P. Association of pre-hospital care and invasive management in patients with myocardial infarction: a single centre study based on the Berlin myocardial infarction registry (Doctoral dissertation).
Lim CT, Ho YH, Fong AY, Ong TK. The clinical and geographical characteristics, health-seeking behaviours of ST-segment elevation myocardial infarction patients with their total ischaemic time and short-term cardiac mortality outcomes: a local geographical perspective from a developing country. Med J Malaysia. 2024 May 1;79(3):257.
Roule V, Schwob L, Briet C, Lemaitre A, Bignon M, Ardouin P, Sabatier R, Blanchart K, Beygui F. Residual platelet reactivity, thrombus burden and myocardial reperfusion in patients treated by PCI after successful pre-hospital fibrinolysis compared to primary PCI. Journal of Thrombosis and Thrombolysis. 2020 Nov;50:858-66.
Bhalerao AV, Tahir SM, Agarwal R. Risk stratification and in-hospital outcome in patients with acute coronary syndrome. Journal of Family Medicine and Primary Care. 2022 Jun 1;11(6):2780-8.
Khan MI, Hasan SK, Saha S, Hossain SZ, Chakrovortty SK. Clinical characteristics and outcomes of percutaneous coronary intervention in acute St-Elevation MI: A study in AFC Fortis Escort Heart Institute, Khulna, Bangladesh. Medico Research Chronicles. 2021 May 15;8(3):169-78.
Koh HP, Md Redzuan A, Mohd Saffian S, Nagarajah JR, Ross NT, Hassan H. The outcomes of reperfusion therapy with streptokinase versus tenecteplase in ST-elevation myocardial infarction (STEMI): a propensity-matched retrospective analysis in an Asian population. International Journal of Clinical Pharmacy. 2022 Jun;44(3):641-50.
Qamar A, Bhatia K, Arora S, Hendrickson M, Gupta P, Fatima A, Mp G, Bansal A, Batra V, Ricciardi MJ, Grines CL. Clinical profiles, outcomes, and sex differences of patients with STEMI: findings from the NORIN-STEMI Registry. JACC: Asia. 2023 Jun 1;3(3_Part_2):431-42.
Dakota I, Dharma S, Andriantoro H, Firdaus I, Danny SS, Zamroni D, Radi B. “Door-in to door-out” delay in patients with acute ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention in a metropolitan STEMI network of a developing country. International Journal of Angiology. 2020 Mar;29(01):027-32.
Rathod KS, Jain AK, Firoozi S, Lim P, Boyle R, Nevett J, Dalby MC, Kalra S, Malik IS, Sirker A, Mathur A. Outcome of inter-hospital transfer versus direct admission for primary percutaneous coronary intervention: An observational study of 25,315 patients with ST-elevation myocardial infarction from the London Heart Attack Group. European Heart Journal: Acute Cardiovascular Care. 2020 Dec 1;9(8):948-57.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2025 ADEEL AHMED, RIMSHA ALI, GHULAM FARID, AHMAD SAQIB, MUHAMMAD ALI, MUHAMMAD MUNEEB, ZOHAIB AKRAM
This work is licensed under a Creative Commons Attribution 4.0 International License.
